Antithrombotic activity of flavonoids and polyphenols rich plant species
Author:
Bojić Mirza1, Maleš Željan2, Antolić Andrea3, Babić Ivana4, Tomičić Maja4
Affiliation:
1. University of Zagreb , Faculty of Pharmacy and Biochemistry Department of Medicinal Chemistry HR-10000 Zagreb , Croatia 2. University of Zagreb , Faculty of Pharmacy and Biochemistry Department of Pharmaceutical Botany HR-10000 Zagreb , Croatia 3. University of Zagreb , Faculty of Science PDS Biology , HR-10000 Zagreb , Croatia 4. Croatian Institute of Transfusion Medicine , HR-10000 Zagreb , Croatia
Abstract
Abstract
Cardiovascular diseases represent one of the most notable health problems of the modern civilization. Stroke and heart attack often lead to lethal outcome; essential problem underneath being thrombus formation. Prophylactic approaches include acetylsalicylic acid and clopidogrel therapy on the level of primary hemostasis, i.e., primary clot formation. In the last five years, in the USA, health care expenses related to cardiovascular diseases have increased 50 %, to over 350 billion dollars. Thus, application of plant species and medicinal plants rich in polyphenols in prevention of thrombus formation are of interest. This is supported by the fact that the number of publications on antiaggregatory effect of polyphenols has doubled in the last decade. In this review we focus on antiaggregatory effect of most abundant polyphenols – flavonoids, the effect of plant extracts rich in polyphenols (propolis, species Salvia sp., Calamintha nepeta L., Lavandula angustifolia Mill., Melissa officinalis L, Mentha x piperita L., Ocimum basilicum L., Origanum vulgare L., Rosmarinus officinalis L.) on platelet aggregation, association of chemical composition and antioxidant properties with the observed biological effect, and possible clinical significance of the published results.
Publisher
Walter de Gruyter GmbH
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Reference57 articles.
1. 1. E. J. Benjamin, P. Muntner, A. Alonso, M. S. Bittencourt, C. W. Callaway, A. P. Carson, A. M. Chamberlain, A. R. Chang, S. Cheng, S. R. Das, F. N. Delling, L. Djousse, M. S. V. Elkind, J. F. Ferguson, M. Fornage, L. C. Jordan, S. S. Khan, B. M. Kissela, K. L. Knutson, T. W. Kwan, D. T. Lackland, T. T. Lewis, J. H. Lichtman, C. T. Longenecker, M. S. Loop, P. L. Lutsey, S. S. Martin, K. Matsushita, A. E. Moran, M. E. Mussolino, M. O’Flaherty, A. Pandey, A. M. Perak, W. D. Rosamond, G. A. Roth, U. K. A. Sampson, G. M. Satou, E. B. Schroeder, S. H. Shah, N. L. Spartano, A. Stokes, D. L. Tirschwell, C. W. Tsao, M. P. Turakhia, L. B. VanWagner, J. T. Wilkins, S. S. Wong and S. S. Virani, Heart disease and stroke statistics-2019 update: A report from the American Heart Association, Circulation139 (2019) e56–e528; https://doi.org/10.1161/cir.000000000000065910.1161/CIR.0000000000000659 2. 2. M. J. Budoff, S. Achenbach, R. S. Blumenthal, J. J. Carr, J. G. Goldin, P. Greenland, A. D. Guerci, J. A. Lima, D. J. Rader, G. D. Rubin, L. J. Shaw and S. E. Wiegers, Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology, Circulation114 (2006) 1761–1791; https://doi.org/10.1161/circulationaha.106.17845810.1161/CIRCULATIONAHA.106.178458 3. 3. P. Greenland, J. S. Alpert, G. A. Beller, E. J. Benjamin, M. J. Budoff, Z. A. Fayad, E. Foster, M. A. Hlatky, J. M. Hodgson, F. G. Kushner, M. S. Lauer, L. J. Shaw, S. C. Smith, A. J. Taylor, W. S. Weintraub and N. K. Wenger, 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, Circulation122 (2010) e584–e636; https://doi.org/10.1161/cir.0b013e3182051b4c10.1161/CIR.0b013e3182051b4c 4. 4. D. L. Bhatt, Can clopidogrel and aspirin lower mortality in patients with acute myocardial infarction? Nat. Clin. Pract. Cardiovasc. Med.3 (2006) 182–183; https://doi.org/10.1038/ncpcardio050810.1038/ncpcardio0508 5. 5. J. Sullivan and N. Amarshi, Dual antiplatelet therapy with clopidogrel and aspirin, Am. J. Health Syst. Pharm.65 (2008) 1134–1143; https://doi.org/10.2146/ajhp06066210.2146/ajhp060662
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sage (Salvia officinalis), Known as "Maramia" in Arabic Culture: An Overview and Herbal Monograph;Pharmacognosy Research;2024-06-14 2. Comprehensive Strategies for Metabolic Syndrome: How Nutrition, Dietary Polyphenols, Physical Activity, and Lifestyle Modifications Address Diabesity, Cardiovascular Diseases, and Neurodegenerative Conditions;Metabolites;2024-06-11 3. Anti-hemostatic, antithrombotic, and chemical profiles of a curly-leaf variety of Petroselinum crispum (Apiaceae), a food and medicinal aromatic herb;Fitoterapia;2024-06 4. Post-operative epidural haematoma as complication of overconsumption of dried fruit in lumbar spinal surgery: a case report and review of the literature;European Spine Journal;2024-05-22 5. Pharmacological Potential of Kaempferol, a Flavonoid in the Management of Pathogenesis via Modulation of Inflammation and Other Biological Activities;Molecules;2024-04-26
|
|